Next Generation News and Research

RSS

LanPercept to focus on advanced techniques for studying language and perception

LanPercept, a new Marie Curie Initial Training Network funded through the 7th EU Framework Programme, will develop cutting edge techniques to understand vision-language mapping across the life-span in typically and atypically developing populations. New tools and training software will be tested to help disabled and elderly people negotiate the translation between vision and language.

15 Nov 2012

Ion AmpliSeq Community Panels from Life Technologies

Life Technologies Corporation today announced Ion AmpliSeq Community Panels, a community-driven solution to gene panel sequencing that leverages the expertise of scientific thought leaders and the Ion Community to create gene panels for conditions ranging from cancer to inherited diseases.

7 Nov 2012

Taiho Pharmaceutical announces early stage data for eight novel oncology compounds

Taiho Pharmaceutical Co., Ltd., the developer of the first orally available fluorouracil (FU) Chemotherapeutic treatment (TS-1/S-1), is presenting early stage data for eight novel oncology compounds, including potential first-in-class therapies.

7 Nov 2012

Keep momentum going to pursue innovation in contraceptive options

"It has been a banner year for media attention, political will and global resources on family planning and women's and girls' rights and empowerment," Ward Cates, president emeritus of FHI 360; Laneta Dorflinger, a scientist with FHI 360; and Kirsten Vogelsong, a senior program officer with the family planning division of the Bill & Melinda Gates Foundation, write in the Huffington Post "Global Motherhood" blog, noting the London Summit on Family Planning, World Contraception Day, and the inaugural International Day of the Girl Child.

6 Nov 2012

New insight on ability of certain PAH-derived lesions to evade DNA repair machinery

A person doesn't have to go far to find a polycyclic aromatic hydrocarbon (PAH). These carcinogen precursors are inhaled through automobiles exhaust during the morning commute, are present in a drag of cigarette smoke, and are part of any barbequed meal.

4 Nov 2012

Mass spectrometry can help visualize how drugs work inside living cells to kill infectious microbes

Weill Cornell Medical College researchers report that mass spectrometry, a tool currently used to detect and measure proteins and lipids, can also now allow biologists to "see" for the first time exactly how drugs work inside living cells to kill infectious microbes.

3 Nov 2012

Physicists to bring to market new drug-discovery tool using genetic sequencing

Today physicists at Wake Forest University and NanoMedica, their biotechnology company partner, received a $700,000 grant from the National Institutes of Health to bring to market a new drug-discovery tool using next-generation genetic sequencing.

3 Nov 2012

New data: 4 in 5 children received recommended doses of DTP vaccine during infancy in 2011

Four in five children (83%) worldwide received the recommended three doses of diphtheria-tetanus-pertussis (DTP) vaccine during infancy in 2011, according to new data released in the Morbidity and Mortality Weekly Report and in the WHO Weekly Epidemiological Record (WER).

2 Nov 2012

Advaxis updates preliminary data from ADXS-HPV Phase 2 trial on cervical cancer

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, updated preliminary data from an ongoing randomized 110 patient Phase 2 trial of ADXS-HPV being conducted in India in women with recurrent/refractory cervical cancer who have failed previous cytotoxic therapy.

1 Nov 2012

Viscus Biologics to develop and commercialize NFB’s new tissue repair material

Viscus Biologics LLC, Cleveland, Ohio, has secured an 18-month option to conduct further research into the development and commercialisation of a new tissue repair material developed by the Network of Excellence for Functional Biomaterials (NFB) at National University of Ireland, Galway.

31 Oct 2012

Complix to accelerate development of CPABs against intracellular disease targets

Complix announces that it has been awarded a €1.9 million grant (approximately USD$2.4 million) from the Flanders government through IWT (Agency for Innovation by Science and Technology in Flanders).

30 Oct 2012

Positive results from Celldex’s CDX-1401 Phase 1 study on solid tumors

Celldex Therapeutics, Inc. today announced positive results demonstrating promising clinical effects in a Phase 1 study of CDX-1401 in solid tumors in combination with the toll-like receptor (TLR) agonists resiquimod and/or Poly ICLC.

30 Oct 2012

St. Luke's cardiologist wins TCT 2012 Geoffrey O. Hartzler Master Clinical Operator Award

Barry D. Rutherford, MD, a world renowned interventional cardiologist, was presented the TCT 2012 Geoffrey O. Hartzler Master Clinical Operator Award in a ceremony held today during the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).

29 Oct 2012

Med school enrollment grows 1.5%

But officials warn that a cap on federally funded residencies could slow the number of doctors coming into the system.

25 Oct 2012

Mesh-covered stent improves restoration of blood flow after PCI in heart attack patients

A clinical trial found that the use of a next generation, micronet, mesh-covered stent demonstrated improved restoration of blood flow to heart tissue, compared to the use of either bare-metal or drug-eluting stents in heart attack patients undergoing angioplasty.

25 Oct 2012

Advaita receives $125,000 Michigan Emerging Technologies Fund award

Advaita Corporation, a startup company based on technology developed at Wayne State University by Sorin Draghici, Ph.D., professor of computer science in the College of Engineering, received the final installment of a $125,000 award from the Michigan Emerging Technologies Fund program.

25 Oct 2012

World-renowned cardiac researchers to speak at SDSU-hosted symposium

Prominent cardiac researchers will meet at San Diego State University in November to explore bold new approaches to treating the number one threat to U.S. adults - heart disease.

24 Oct 2012

Weill Cornell’s ChiP now accepts applications for new master's program in health informatics

Informatics is integral to solving the nation's urgent healthcare issues of rising costs and the delivery of quality care. Training the next generation of professionals to develop, implement and research new informatics technologies is vital. Through the Weill Cornell Graduate School of Medical Sciences, the Center for Healthcare Informatics and Policy (CHiP) is now accepting applications for a new master's program in health informatics to do just that.

24 Oct 2012

K2M to exhibit comprehensive product portfolio at the North American Spine Society (NASS) Annual Meeting

K2M, Inc., the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced that with the recent addition of multiple breakthrough technologies, K2M offers a market leading comprehensive product portfolio to be exhibited at the North American Spine Society (NASS) Annual Meeting.

23 Oct 2012

Adachi purchases Mazor Robotics' Renaissance surgical guidance system for spine procedures

Mazor Robotics Ltd., a developer of innovative surgical robots and complementary products, today announced that Adachi Medical Instruments Co., Mazor's distribution partner in Japan, placed an order for its Renaissance™ system. As part of the distribution agreement, Adachi is committed to obtain Japanese PMDA (Pharmaceuticals and Medical Devices Agency) approval for the Renaissance system.

22 Oct 2012

Next Generation News and Research

LanPercept to focus on advanced techniques for studying language and perception

Ion AmpliSeq Community Panels from Life Technologies

Taiho Pharmaceutical announces early stage data for eight novel oncology compounds

Keep momentum going to pursue innovation in contraceptive options

New insight on ability of certain PAH-derived lesions to evade DNA repair machinery

Mass spectrometry can help visualize how drugs work inside living cells to kill infectious microbes

Physicists to bring to market new drug-discovery tool using genetic sequencing

New data: 4 in 5 children received recommended doses of DTP vaccine during infancy in 2011

Advaxis updates preliminary data from ADXS-HPV Phase 2 trial on cervical cancer

Viscus Biologics to develop and commercialize NFB’s new tissue repair material

Complix to accelerate development of CPABs against intracellular disease targets

Positive results from Celldex’s CDX-1401 Phase 1 study on solid tumors

St. Luke's cardiologist wins TCT 2012 Geoffrey O. Hartzler Master Clinical Operator Award

Med school enrollment grows 1.5%

Mesh-covered stent improves restoration of blood flow after PCI in heart attack patients

Advaita receives $125,000 Michigan Emerging Technologies Fund award

World-renowned cardiac researchers to speak at SDSU-hosted symposium

Weill Cornell’s ChiP now accepts applications for new master's program in health informatics

K2M to exhibit comprehensive product portfolio at the North American Spine Society (NASS) Annual Meeting

Adachi purchases Mazor Robotics' Renaissance surgical guidance system for spine procedures

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News